{{Rsnum
|rsid=7652589
|Chromosome=3
|position=122170241
|Orientation=plus
|GMAF=0.4219
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 14.2 | 44.3 | 41.5
| HCB | 40.3 | 44.8 | 14.9
| JPT | 35.8 | 56.0 | 8.3
| YRI | 16.1 | 51.0 | 32.9
| ASW | 10.5 | 59.6 | 29.8
| CHB | 40.3 | 44.8 | 14.9
| CHD | 39.4 | 47.7 | 12.8
| GIH | 27.3 | 46.5 | 26.3
| LWK | 15.7 | 54.6 | 29.6
| MEX | 3.4 | 36.2 | 60.3
| MKK | 20.6 | 44.5 | 34.8
| TSI | 13.9 | 49.5 | 36.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=20067903
|Title=Calcium [[kidney stones]] are associated with a haplotype of the Calcium-sensing receptor gene regulatory region
}}

{{PMID Auto
|PMID=22107799
|Title=Calcium-sensing receptor and calcium kidney stones
|OA=1
}}

{{PMID|21183554}} Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism.

{{PMID Auto
|PMID=22660550
|Title=Calcium-sensing receptor gene polymorphisms in patients with calcium nephrolithiasis.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}